Recent Finacing
Recent Raise
t-cell Europe GmbH develops IP-protected regulatory T cell (Treg) therapies, focusing on a kidney-transplant Treg product and pharmaceutical-grade platform validation prior to clinical studies.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
